It's All About/Nonprofit Foundation/Henderson/Curing Type 1 Diabetes
The second major explosion nearly destroyed the chief’s car; after he and his passenger were cut by flying glass, he was able to drive the damaged vehicle to a hospital. The windshields of a responding Henderson Fire Department vehicle were blown in, injuring the driver and firefighters with shattered glass.
Several nearby fire departments responded to the accident. Clark County units staged 1.5 miles (2.4 km) from the scene and assisted injured firefighters. The explosions and the raging fire were beyond their firefighting capabilities and they made no attempt to approach or fight the fire in recognition of the danger it posed.
At about 11:54, as he approached the site, the first of the two major explosions sent a shock wave that shattered the windows of his car and showered him and his passenger with glass. The driver of a heavily damaged vehicle coming away from the plant then advised the chief about the danger of subsequent larger explosions, which prompted the chief to turn around and head back toward his station. The other units also stopped heading toward the site after the explosion. JDRF’s research goal is to discover, develop, and deliver advances that progressively remove the impact of T1D from people’s lives until we find a cure. JDRF is driving research across the entire scientific spectrum, from discovery in the laboratory to delivery of new technologies and treatments to people with T1D.
The full impact of JDRF’s research investment extends well beyond our direct funding. Now more than ever, we see the value in leveraging partnerships with academia, industry and clinicians to ensure that the most promising research opportunities are funded and accelerated. JDRF often provides early-stage funding to research projects, and the results of those projects often lead to follow-on participation from many other entities – both other not-for-profit funders and corporations. Type 1 diabetes (Juvenile Diabetes) is usually diagnosed in children and young adults, and was previously known as juvenile diabetes. Only 5% of people with diabetes have this form of the disease.
In type 1 diabetes, the body does not produce insulin. The body breaks down the sugars and starches you eat into a simple sugar called glucose, which it uses for energy. Insulin is a hormone that the body needs to get glucose from the bloodstream into the cells of the body. With the help of insulin therapy and other treatments, even young children can learn to manage their condition and live long, healthy lives.
18.2 million people in the United States (6.3 percent of the population) have been diagnosed with diabetes. 5 to 10 percent of all people with diabetes have Type 1 Diabetes (T1D). The Health Care and Social Assistance industry includes establishments and services such as:
hospitals, nursing and residential care facilities and out-patient care centres; offices of health practitioners (i.e. dentists, doctors, optometrists and chiropractors); medical and diagnostic laboratories; home health care services; ambulance services; social assistance services (i.e. for children, youth, the elderly, families); community food, housing, emergency and relief services; vocational rehabilitation services; and daycare services All Video Credits are listed here http://broadcaster.beazil.net/public/credits/youtube/videos/41691 JDRF is the leading global organization funding type 1 diabetes (T1D) research. JDRF’s goal is to progressively remove the impact of T1D from people’s lives until we achieve a world without T1D. JDRF has led the search for a cure for T1D since our founding in 1970. In those days, people commonly called the disease “juvenile diabetes” because it was frequently diagnosed in, and strongly associated with, young children. Our organization began as the Juvenile Diabetes Foundation. Later, to emphasize exactly how we planned to end the disease, we added a word and became the Juvenile Diabetes Research Foundation.Today, we know an equal number of children and adults are diagnosed every day—approximately 110 people per day.
To sum up, the major issues that were mentioned are:
low-density lipoprotein cholesterol,diabetes insipidus,oral hypoglycemic agents,Recognized Diabetes Education Programs,precise,Abstracts of JDRF Research,very-low-density lipoprotein cholesterol,T1D,support our research,GDM,amputation,diabetes advocacy,DKA,Glucagon-like peptide 1 agonists,ultralente insulin,Roche Diabetes Care,Grassroots fundraising,Diabetes Care,The Silver State,miglitol,gestational diabetes mellitus,Medical Device,Cure Diabetes,Team Cure Diabetes,GLP-1 agonists,children diabetes,Greater Louisville Walk,secondary diabetes,prevention,Type 1 Diabetes,A1C complications,insulin analogues,Henderson,T1D Mentors,Glucose Modulating Agents,T1D complications,latent autoimmune diabetes in adults,hypoglycemia unawareness,therapeutic strategies,Kidney Disease,T1D Community,Managing Type.